Feb. 8, 2008 -- The FDA has cleared for marketing GelSpray Liquid Bandage.
The product is a spray-on treatment for wounds -- including combat wounds -- according to a news release from Rutgers, the State University of New Jersey.
The product releases polymers from a two-barreled syringe. The polymers mix into a "gel-based dressing that frontline combat soldiers can apply to their own wounds," states the Rutgers news release.
Rutgers' Center for Military Biomaterials Research collaborated with BioCure, a company based in Norcross, Ga., to create the product. BioCure will market the product.
Other liquid bandages are already on the market. Those products have "more similarities than differences" with GelSpray Liquid Bandage, according to FDA documents.